The striking cisplatin-induced nephropathy in the prophylactic and curative control groups was exhibited by increased levels of serum urea, serum creatinine, and tissue MDA and reduced levels of serum total protein and tissue CAT as compared to the control group at p < 0.05. This evidence concerns the gene CAT and kidney disorder.